1. The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
    Juanjuan Xu et al, 2017, Front. Physiol. CrossRef
  2. Angiotensin II promotes endometrial cancer cell survival
    Magdalena Nowakowska et al, 2016 CrossRef
  3. Angiotensins as therapeutic targets beyond heart disease
    Danielle Gomes Passos-Silva et al, 2015, Trends in Pharmacological Sciences CrossRef
  4. Lack of association between ACE insertion/deletion polymorphism and lung cancer: A meta-analysis
    Zhenshun Cheng et al, 2015, J Renin Angiotensin Aldosterone Syst CrossRef
  5. Expression and function of the ACE2/angiotensin(1–7)/Mas axis in osteosarcoma cell lines U-2 OS and MNNG-HOS
    STEPHAN ALBRECHT ENDER et al, 2014 CrossRef
  6. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease.
    Mohit Kumar Jolly et al, 2018, Dev Dyn CrossRef
  7. Acetylation and amination protect Angiotensin 1-7 from physiological hydrolyzation and therefore increase its anti-tumour effects on lung cancer
    Xiaowen Ma et al, 2018, Mol. Pharmaceutics CrossRef
  8. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
    Qi Zhang et al, 2019, J Exp Clin Cancer Res CrossRef
  9. Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis
    Yongmei Cao et al, 2019, Lab Invest CrossRef
  10. The central renin–angiotensin system and sympathetic nerve activity in chronic heart failure
    Irving H. Zucker et al, 2014, Clin. Sci. CrossRef
  11. Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer
    Huajie Zong et al, 2015, Tumor Biol. CrossRef
  12. Lack of an Association between Angiotensin Receptor Blocker Based Therapy and Increased Risk of Cancer: Evidence from Large Observational Studies
    Yuan Yang et al, 2015, PLoS ONE CrossRef
  13. Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib
    Adnan Aydiner et al, 2015, Medicine CrossRef
  14. Downregulation of ACE2/Ang-(1–7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry
    Changhui Yu et al, 2016, Cancer Letters CrossRef
  15. Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice
    Indu G. Rajapaksha et al, 2019, Hepatol Commun CrossRef
  16. Epithelial Mesenchymal Transition in Respiratory Disease
    Darryl A. Knight et al, 2020, Chest CrossRef
  17. SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
    Ishita Gupta et al, 2020, Cancers CrossRef
  18. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
    Huan Feng et al, 2020, Front. Mol. Biosci. CrossRef
  19. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses
    Abdus Samad et al, 2020, Genomics CrossRef
  20. Characterization of the Renin-Angiotensin System in Aged Cavernosal Tissue and its Role in Penile Fibrosis
    Maiia E. Bragina et al, 2020, The Journal of Sexual Medicine CrossRef
  21. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Federica Saponaro et al, 2020, Front. Mol. Biosci. CrossRef
  22. Kathon Induces Fibrotic Inflammation in Lungs: The First Animal Study Revealing a Causal Relationship between Humidifier Disinfectant Exposure and Eosinophil and Th2-Mediated Fibrosis Induction
    Mi-Kyung Song et al, 2020, Molecules CrossRef
  23. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes
    Vikas Kumar Bhari et al, 2020, Biochemistry and Biophysics Reports CrossRef
  24. Mesoporous silica nanoparticles loaded with alamandine as a potential new therapy against cancer
    Nádia Miriceia Leão et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
  25. ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
    Prateek Khanna et al, 2021, Sci. Transl. Med. CrossRef
  26. High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis
    DHR-ICMR Young Scientist Madhumathy G Nair et al, 2021, Cancer Treatment and Research Communications CrossRef
  27. Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System
    Sam Siljee et al, 2021, Cells CrossRef
  28. ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19
    Xinhao Niu et al, 2021, Journal of Oncology CrossRef
  29. Evaluation of the Susceptibility and Fatality of Lung Cancer Patients towards the COVID-19 Infection: A Systemic Approach through Analyzing the ACE2, CXCL10 and their Co-expressed Genes
    Tousif Bin Mahmood et al, 2021, Current Research in Microbial Sciences CrossRef
  30. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response
    Serhiy Souchelnytskyi et al, 2021, Sci Rep CrossRef
  31. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19
    Mohsen Ahmadi et al, 2021, International Immunopharmacology CrossRef
  32. Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection
    Long Chen et al, 2021, Aging CrossRef
  33. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
    Qianqian Wang et al, 2021, Front. Oncol. CrossRef
  34. Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
    Thomas Walther et al, 2021, Molecular & Cellular Oncology CrossRef
  35. The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation
    Kandi Xu et al, 2021, Front. Oncol. CrossRef
  36. Decipering the Molecular Mechanism of ACE2 Regulating A549 Cells
    Kun Xiao et al, 2021, Front. Genet. CrossRef
  37. Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues
    Wei-Jian Huang et al, 2021, Bioengineered CrossRef
  38. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology
    C. Allison Stewart et al, 2021, Journal of Thoracic Oncology CrossRef
  39. Downregulation of ACE2 is associated with advanced pathological features and poor prognosis in clear cell renal cell carcinoma
    Tianjiao Wang et al, 2021, Future Oncology CrossRef
    A. S. Pathania et al, 2021, Juvenis scientia CrossRef
  41. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues
    Karthikeyan Subbarayan et al, 2021, CCDT CrossRef
  42. Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19
    Ikram Omar Osman et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
  43. null
    Avinash Arvind Rasalkar et al, 2022 CrossRef
  44. Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy
    Xiaoyan Zuo et al, 2022, J Transl Med CrossRef
  45. Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype
    Andreas E. Albers et al, 2017, Sci Rep CrossRef
  46. 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging
    Fangyuan Ren et al, 2023, Eur J Nucl Med Mol Imaging CrossRef
  47. null
    Qing Lin et al, 2023 CrossRef
  48. null
    Jinxuan Su et al, 2023 CrossRef
  49. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
    Melanie Engler et al, 2023, Life Sci. Alliance CrossRef
  50. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
    Chia-Wen Wang et al, 2023, J Biomed Sci CrossRef
  51. E-Cadherin and its signaling pathways: A novel target of dietary components in modulating cell migration and proliferation
    Fatemeh Ashkar et al, 2024, Trends in Food Science & Technology CrossRef
  52. An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancer
    Hexiao Tang et al, 2024, JTCVS Open CrossRef
  53. Association Between ACE2 and Lung Diseases
    Cheng Su et al, 2024, IDR CrossRef
  54. Expression of Angiotensin Converting Enzyme 2 in patients with Oral Squamous Cell Carcinoma.
    Shivani Sivasakthivel et al, 2024, Oral Oncology Reports CrossRef
  55. Modulation of ACE2/Ang1-7/Mas and ACE/AngII/AT1 axes affects anticancer properties of sertraline in MCF-7 breast cancer cells
    Reihaneh Fatehi et al, 2024, Biochemistry and Biophysics Reports CrossRef